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Abstract Ganglioneuroma is a rare, benign, non-invasive tumor 
emerging from the sympathetic system. Of these tu-
mors, only 8% occur in the neck. In this report, we 
present a case of a 13-year-old girl with a 2-year 
history of enlarging neck mass. Her only complaint, 
aside from neck swelling, was dysphagia. Physical and 
radiological examinations revealed a large mass cen-
tered in the right carotid space. A transcervical ap-
proach was used to excise the tumor emerging from 
the sympathetic ganglia. The patient developed tem-
porary Horner's syndrome postoperatively. In a few 
weeks, she was completely asymptomatic. Histolog-
ical examination was compatible with ganglioneuro-
ma. Surgical excision is the only definite treatment of 
cervical ganglioneuroma and is also the only way to 
confirm the diagnosis. Injury during surgery may re-
sult in significant morbidity.
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Introduction
Cervical masses in pediatric patients are usually 
classified into one of the three categories: devel-
opmental, inflammatory/reactive, or neoplastic 
(1). Onset and duration of symptoms, exposures 
(animals and other sick children), and location can 
aid in the differential diagnosis. Neoplastic lesions 
can be either benign or malignant, with the latter 
being rare in this age group (2).
Ganglioneuroma, together with ganglioneuro-
blastomas (intermixed and nodular) and neuro-
blastomas, comprises a group of tumors called 
peripheral neuroblastic tumors (3-5). It is a 
rare, benign, non-invasive tumor which usual-
ly emerges from the sympathetic ganglia. It is 
most frequently located in the abdomen (poste-
rior mediastinum, retroperitoneum, and adrenal 
glands) in 65%-80% of cases, followed by the 
thorax in 10%-15%, with the neck region as its 
rarest location in 5%-8% of patients (6, 7). It typ-
ically presents as an enlarging mass of the neck. 
Its symptoms usually stem from mass effect and 
nerve dysfunction.
Case Presentation
A 13-year-old girl presented for evaluation at the 
otorhinolaryngology department with a history of 
a 2-year enlarging neck mass. She had previously 
been followed up by a pediatric surgeon and had 
undergone echo-guided biopsy, which was incon-
clusive. She had recently started with complaints 
of dysphagia. On examination, a medial bulging 
of the right lateral pharyngeal wall accompanied 
by cervical right swelling was noted. It had nor-
mal overlying skin and was elastic in consistency, 
tender, and mobile. Magnetic resonance imaging 
(MRI) showed a mass of 35×60 mm centered in 
the right carotid space (Figure 1, 2). The mass dis-
placed anteriorly the internal and external carotid 
arteries and collapsed posteriorly the internal jug-
ular vein. Blood and urine results were negative for 
by-products of sympathetic response, including 
vanillylmandelic acid and hydroxymandelic acid. 
Surgical excision was planned.
Under general anesthesia, a transcervical approach 
was used to excise the tumor (Figure 3). The vagus 
nerve was identified and preserved, as were the ac-
cessory and hypoglossal nerves. The internal jugular vein and the 
common carotid artery which were displaced by the tumor were 
retracted and also preserved. The tumor was derived from the 
sympathetic chain, which ramified into the mass. The excised le-
sion was well circumscribed, making an intact removal possible 
(Figure 4). In spite of being in continuity with the sympathetic 
chain, this was left intact.
The patient was extubated immediately after the surgery 
with no clinical signs of respiratory distress. The patient 
developed temporary Horner’s syndrome postoperatively, 
characterized by ipsilateral ptosis, myosis, and asymmetry 
of the lower eyelid, with full recovery within the first month 
postoperatively. Histopathological examination revealed 
ganglioneuroma(Figure 5). The patient has been followed 
up for 24 months with no signs of recurrence. Written in-
formed consent was obtained for this case report from the 
parents of the patient.
Figure 1. MRI (T2) coronal section shows a mass of 35×60 mm 
centered in the right carotid space, extending to the skull base
*tumor, #: pharynx
Figure 2. MRI (T2) axial section shows a mass of 35×60 mm 
centered in the right carotid space, extending to the skull base
*tumor, +: internal jugular vein,→: carotid artery, #: pharynx
Figure 3. A well-circumscribed mass which emerged from the 
sympathetic chain
Figure 4. Surgical specimen
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Discussion
Ganglioneuroma was first described by Loretz in 1870 (8). It 
originates from the primordial neural crest cells which are un-
differentiated cells of the central nervous system (6, 7). These 
cells are present in the sympathetic ganglia and adrenal medulla, 
indicating that these tumors may grow nearly anywhere along 
their distribution.
Ganglioneuroma usually occurs in the abdomen or thorax, but it 
can also occur in the head and neck region, with the latter being 
its least common location (6). Actually, this is one of the rarest 
neck tumors (6-10). The first report of a ganglioneuroma located 
in the neck was made in 1899 by de Quervain (8). The most fre-
quent origin in the neck region is the cervical sympathetic chain, 
but it can also be located in the larynx, pharynx, and ganglion 
nodosum of the vagus nerve (9).
These types of tumors are more common at a young age, as 60% 
of patients with ganglioneuroma are <20 years old (6, 10). The 
average age of presentation is 11 years old, with a slight prepon-
derance in the female gender (10).
They are usually slow-growing masses, with most of them being 
silent in the early stages of development (6). Their symptoms are 
a consequence of compression of the neighboring structures, as 
in the descripted case who presented with dysphagia. Globus 
sensation, dyspnea, voice change, and nasal congestion can be 
due to the tumors’ expansion. They can also cause nerve dys-
function.
The reviewed literature suggests the possibility of these tumors 
being secretory; however, our case and the ones reviewed were 
not metabolically active (7-10). Nevertheless, the differential 
diagnosis between ganglioneuroma and neuroendocrine tumors 
can be quite difficult. According to the North American Neu-
roendocrine Tumor Society guidelines, the initial testing for 
pheochromocytoma or paraganglioma must include measure-
ments of fractionated metanephrines in plasma, urine, or both, 
as available. Given their high sensitivity for neuroendocrine tu-
mors (reaching 100% in children and 99% in adults), they are 
part of the initial routine evaluation of this kind of masses (11).
In other case series, fine-needle aspiration failed to identify this 
kind of tumor in 60% of cases (10). Nevertheless, it can be of 
tremendous value in the differential diagnosis in pediatric pa-
tients, as it is a rapid, safe and cost-effective method, although 
sedation is often required (7).
In addition, imaging is crucial not only on the differential di-
agnosis of the neck mass but also to plan surgery. Generally, 
both computed tomography (CT) and MRI are mandatory. 
CT frequently reveals a well-defined mass, which displaces the 
surrounding structures (6). MRI shows intermediate signal in-
tensity and cystic or non-homogeneous contrast enhancement. 
On the other hand, functional imaging with metaiodobenzyl-
guanidine scintigraphy has a high specificity for neuroendocrine 
tumors and can aid in the precise localization of that kind of 
disease. Several authors report having used it preoperatively for 
differential diagnostic purposes. This examination was not used 
in our patient as the by-products of sympathetic response were 
negative (11). As in our case, preoperative diagnosis is not pos-
sible most of the times.
Surgical resection of these tumors is the gold standard treatment 
(6-10). The approach may vary. As in our case, a transcervical 
approach can be used; however, transoral, transparotid, trans-
cervical–transpharyngeal, and infratemporal fossa approach can 
also be used depending on the location, size, and pathological 
type (10). Mandibulotomy has also been performed in a few 
cases for better exposure of the skull base (10). Damage to the 
nearby neural and vascular structures during surgery may result 
in significant morbidity (8). However, these symptoms tend to 
resolve rapidly (7).
Definitive diagnosis is based on histopathological analysis. The 
International Neuroblastoma Pathology Classification defines 
four categories of peripheral neuroblastic tumors characterized 
by the grade of neuroblastic differentiation and the degree of 
Schwannian stromal development (5). Neuroblastomas are cel-
lular neuroblastic tumors without prominent Schwannian stro-
ma. Ganglioneuroblastomas are subdivided into intermixed and 
nodular categories. The former comprises neuroblastic elements 
in an abundant Schwannian stroma, and the latter is a compos-
ite tumor with a neuroblastic nodular component and either an 
intermixed ganglioneuroblastoma or a ganglioneuroma compo-
nent. As in our case, ganglioneuromas represent the most dif-
ferentiated form, consisting of mature ganglion cells distributed 
in a predominant Schwannian stroma. Ganglion cells vary in 
distribution and number and can be either localized or widely 
scattered. Schwann cells may ensheath neuritic processes or may 
be arranged in small intersecting fascicles, which are separated 
by loose myxoid stroma. Neuroblasts should be negative in order 
to make this diagnosis. Furthermore, significant atypia, mitoses, 
or necrosis must be absent (4, 5).
Figure 5. Microscopic examination revealed ganglioneuroma, 
namely clusters of mature ganglion cells and intersecting bundles of 
spindle cells (H&E, X100)
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If the diagnosis is confirmed after surgical excision, it can be 
curative. The prognosis is favorable, as ganglioneuromas do not 
have metastatic potential (10). The patient does not require fur-
ther treatment. Even in the case of incomplete resection, it does 
not have the potential to recur (5). Radiation should be avoided 
in these cases, especially in young ages, as it can cause growth 
retardation and later problems (6). On the other hand, other 
categories of neurogenic tumor have different behaviors. Neuro-
blastoma is a malignant solid tumor, and ganglioneuroblastoma 
has moderate malignant potential, which may require the need 
for close follow-up and for complimentary treatment, such as 
chemo- or radiotherapy.
Moreover, isolated ganglioneuromas can also occur in associ-
ation with at least two syndromes, namely multiple endocrine 
neoplasia type 2B and type I neurofibromatosis (10). A family 
history of any of these two should be assessed, and if positive, 
further study is recommended.
Conclusion
Surgical excision is the only definite treatment of cervical gan-
glioneuroma to prevent further growth and compression of the 
neighboring structures. It is also the only way to confirm the 
diagnosis. These tumors are usually not aggressive. Injury during 
surgery may result in significant morbidity.
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